title: [Study on immune efficacy of Newcastle disease chitosan microsphere vaccine].
abstract: Newcastle disease is an acute and highly contagious disease caused by Newcastle disease virus (NDV), one of which does great harms to the poultry industry. The most basic measure of controlling New Castle disease is to alid vaccine, now we usually use La Sota live vaccine and inactivated NDV vaccine, but these two vaccines both have more or less limitation. It can produce higher mucosal immunity titers by taking vaccine orally, meanwhile it can induce humoral and cell-mediated immune response and mucosal immunity strongly. Therefore, it becomes the focus of the research, which prepare new pattern vaccines taking orally. NDV chitosan microsphere vaccine was prepared using chitosan as capsule wall material, NDV as core material, glutaraldehyde as cross-linking material, and its even particle diameter was 5.83um, and its surface was smooth and glossy, no obviously pore space, yellow brown pykno-ball, and its safety and potency were evaluated. The SPF chickens were immunized with NDV chitosan microsphere vaccine, La Sota live vaccine and inactivated NDV vaccine respectively. To evaluate vaccine's immune efficacy, using MTT to measure lymphocytes proliferation in vitro, using HI to measure serum special IgG and using ELISA tests to detect mucosal sIgA titers. The results show that NDV chitosan microsphere vaccine was safe, could induce humoral and cell-mediated immune response and mucosal immunity strongly. The results of the potency tests conformed that the vaccine could produce good protective effect.
authors.affiliation: College of Veterinary Medicine, Shandong Agriculture University, Tai' an 271018, China. rlingzhai@163.com
authors.forename: Rong-ling
authors.initials: RL
authors.lastname: Zhai
authors.forename: Huai-ying
authors.initials: HY
authors.lastname: Xu
authors.forename: You-ling
authors.initials: YL
authors.lastname: Wang
authors.forename: Zhuo-ming
authors.initials: ZM
authors.lastname: Qin
authors.forename: Shi-jin
authors.initials: SJ
authors.lastname: Jiang
mesh_terms: D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D002645:Chickens; D048271:Chitosan / Q000008:administration & dosage / Q000737:chemistry / Q000276:immunology*; D007071:Immunoglobulin A, Secretory / Q000032:analysis / Q000276:immunology; D007074:Immunoglobulin G / Q000097:blood; D008863:Microspheres; D009521:Newcastle Disease / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D009522:Newcastle disease virus / Q000737:chemistry / Q000276:immunology*; D011201:Poultry Diseases / Q000276:immunology* / Q000517:prevention & control / Q000821:virology; D011897:Random Allocation; D014611:Vaccination; D014765:Viral Vaccines / Q000008:administration & dosage / Q000737:chemistry / Q000276:immunology*
chemical_list: D000914:Antibodies, Viral; D007071:Immunoglobulin A, Secretory; D007074:Immunoglobulin G; D014765:Viral Vaccines; D048271:Chitosan